-
Hello, everyone. And thank you for
-
tuning in to live from NCS. This is
-
Casey Elbin. I am so delighted to talk
-
today about the incredible offerings
-
from the conference. Today is Thursday,
-
August 17. And so we're going to
-
highlight just a couple of the sessions
-
that we found were really exciting and
-
discuss a couple of the pearls that some
-
of the presenters shared I think we'll
-
be really exciting and hopefully make
-
you excited to tune in to on demand if
-
you were not able to attend this session
-
in person. So to start off, I think
-
just highlighting that our keynote
-
address was given today by Dr Mona Kumar
-
from Penn and Dr Cara Melmed from NYU,
-
looking at the importance of health care
-
disparities in our neuro critical care
-
population Such important work as we as
-
a field seek to better understand how
-
socio-economic racial and ethnic
-
diversity are linked to disparities that
-
really impact recovery and even
-
mortality. I thought Director Kumar's
-
talk was really interesting as it
-
explored the impact of the current
-
political and social factors on patient
-
autonomy. And that was particularly
-
looking at marginalized and minority
-
population and neurocritical care and
-
how the consequences of this compromised
-
patient autonomy can impact really
-
important outcomes like brain deaths,
-
termination, and organ transplantation.
-
And I think she really emphasized how
-
organ transplant also are going to
-
minoritized communities. And it's
-
really important that we consider
-
patient autonomy when we're navigating
-
this really complicated and
-
can be emotionally fraught aspect of
-
kind of one of the core components that
-
we're doing at the bedside.
-
Dr. Malmed reviews their retrospective
-
analysis of zip code as a marker of
-
social determinants of health and how
-
this impacts mortality after ICH. And I
-
don't think their findings come really
-
as a surprise showing that if you live
-
in a lower socioeconomic zip code that
-
your mortality is higher. But I think
-
it was really important to highlight
-
that we have hard data showing that now
-
and how important it is given that we
-
invest so much in the acute care of
-
these patients that we really need to
-
invest in their longitudinal care as
-
well to make sure that
-
really the benefit of all that acute
-
care translates into longitudinal
-
outcomes. Another of the sessions that
-
we wanted to highlight today is the care
-
of the cardiac patient. This is a
-
constant source of consult stress for
-
neurointensivists as we are called to
-
help prognosticate and to investigate
-
brain recovery for patients who are
-
suffering from a cardiovascular illness
-
So Dr. Ryan Prainer. Dr. Kara Melman
-
and Dr. Sun Min Cho discussed the
-
mechanical support and neuromonitoring
-
in these patients. And I was able to
-
talk with Dr. Cho who really gave me
-
some pearls. This ECMO-associated brain
-
injury is common. And in fact, a nice
-
pearl about it is that it doubles and
-
triples the mortality in both VA and VV
-
ECMO patients. And there's likely a
-
causal relationship between ECMO and
-
acute brain injury. They discuss in
-
this session how early detection of
-
acute brain injury is really critical.
-
And we really need to take a
-
standardized approach to having a
-
monitoring protocol with really
-
comprehensive neurocritical care to
-
improve the neurologic outcomes of these
-
patients. And I think one of the really
-
interesting and one of the things that's
-
coming down the pipeline is how MRI can
-
be used to substantially improve our
-
ability to diagnose acute re-injury.
-
Obviously, these patients can't be
-
transported. Many of them have devices
-
that are not safe and MRI compatible,
-
but how the safe MRI ECMO study is
-
really moving the needle with point of
-
care MRI that can be done for these
-
patients. And so that really is one of
-
the future applications of a
-
neuropregnostication in these patients.
-
Another important session today was the
-
guideline updates in the late breaking
-
science, which covered some of the
-
topics of
-
delirium and rapid EEG seizure
-
assessment and going through the safer
-
trial. We also looked at various dual
-
anti-apletelet therapy strategies for
-
neuroendvascular scents. Then my
-
colleague, Dr. Salia Farok, will
-
review the role of ketamine in status
-
epilepticus as a separate podcast from
-
the Live from NCS series. So I'm gonna
-
skip that and talk about this really
-
exciting concurrent session, which was
-
the road to the future and assessing the
-
unresponsive patient. This was led by
-
Dr. Alcarom, Dr. Klassen, and Dr.
-
Mushlegal, who talk about how early
-
prognostication is often inaccurate and
-
how functional recovery is more likely
-
if the unresponsive patient has minimal
-
clinical signs of interaction with the
-
environment. But figuring that out is
-
actually really quite difficult in
-
today's neuroassessments. And so an
-
important pearl that they give in this
-
session is that up to one in every five
-
behaviorally unresponsive patients has
-
evidence of preserved consciousness when
-
tested with motor paradigms, utilized
-
in functional MRI or EEG paradigms. And
-
they really talk about this state being
-
the state of covert consciousness. And
-
so this session goes through the current
-
state of detecting covert consciousness,
-
discusses proposed mechanisms that
-
underlie this state, insight into how
-
using high tracking and EEG, we're
-
going to be able in the future to better
-
understand which of our patients are
-
likely to make a recovery. And I think
-
one of the things that is hard about
-
this is that given that these are sort
-
of novel prognostication tools and that
-
we are going to have to learn their
-
application, we're going to be learning
-
that alongside the families. And how do
-
we talk to families about this so that
-
they can integrate this novel
-
information into their decision making
-
that best gives the chance for their
-
loved one to really
-
you know meet a standard that is
-
acceptable to the patient and you know
-
how do we use shared decision making in
-
some of these novel situations. And
-
then finally I think one of the more
-
interesting sessions this afternoon was
-
this critical conversations doing 360
-
feedback in the ICU And so, Shwita
-
Goswami at the University of Florida,
-
you know, gave a really insightful
-
presentation about what it means to be a
-
trainee in a teen dynamic situation like
-
a neurocritical care team. And so she's
-
really gone into sort of
-
the science of learning how to be a
-
member of a highly functioning team.
-
And that's really important because as a
-
neurocritical care trainee, you're not
-
just becoming a neurointensivist,
-
you're training to become the leader of
-
a multidisciplinary team. And so she
-
gives a sort of broad overview of some
-
of the really, you know, behavioral
-
like science-based tenets of a
-
high-performing team such as leadership
-
style and establishing psychological
-
safety and using emotional intelligence
-
and how do you establish mutual
-
accountability in the care of these
-
patients? Because we are all caring for
-
a neurocritical care patient as a team
-
and each member of that team has to
-
really contribute so that the patient
-
gets the best outcome. So I thought
-
that was a really exciting session as
-
well. There are many, many more
-
sessions that we obviously could not
-
highlight all. And today's live from
-
NCS podcast, but I do hope that you'll
-
check out the schedule. And I hope that
-
if you missed some of these exciting
-
sessions that we've featured here, that
-
you'll be able to catch them on demand.
-
All right, until tomorrow.